BGIM
PBYI icon

Brandywine Global Investment Management’s Puma Biotechnology PBYI Stock Holding History

Brandywine Global Investment Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$130K Buy
+21,800
New +$116K ﹤0.01% 594
2024
Q3 		– Sell
-32,210
Closed -$105K – 716
2024
Q2 		$105K Buy
+32,210
New +$141K ﹤0.01% 677
2023
Q1 		– Sell
-318,601
Closed -$1.35M – 744
2022
Q4 		$1.35M Hold
318,601
– – 0.01% 616
2022
Q3 		$755K Sell
318,601
-11,899
-4% -$34.7K 0.01% 649
2022
Q2 		$942K Sell
330,500
-49,500
-13% -$123K 0.01% 615
2022
Q1 		$1.09M Hold
380,000
– – 0.01% 615
2021
Q4 		$1.16M Buy
+380,000
New +$1.65M 0.01% 574

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return